PROTEINURIC KIDNEY DISEASE
Clinical trials for PROTEINURIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROTEINURIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for PROTEINURIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets genetic cause of kidney failure
Disease control Recruiting nowThis clinical trial is testing whether an investigational drug called VX-147 can help slow kidney damage in people who have a specific genetic risk (APOL1 mutations) that causes protein to leak into their urine. The study will enroll 466 adults and children to compare VX-147 agai…
Matched conditions: PROTEINURIC KIDNEY DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial targets genetic cause of kidney damage
Disease control Recruiting nowThis study is testing an investigational drug called Inaxaplin for people with a specific genetic form of kidney disease (APOL1-mediated). The main goal is to see if the drug safely reduces the amount of protein leaking into the urine, which is a key sign of kidney damage. The tr…
Matched conditions: PROTEINURIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug targets genetic cause of kidney damage
Disease control Recruiting nowThis study is testing an investigational drug called MZE829 in adults with chronic kidney disease who have a specific high-risk genetic type (APOL1). The main goals are to see if the drug is safe and if it can reduce the amount of protein leaking into the urine, which is a sign o…
Matched conditions: PROTEINURIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: Maze Therapeutics • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC